{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-25-137162","form_type":"8-K","ticker":"RLAY","cik":"0001812364","company_name":"Relay Therapeutics, Inc.","filed_at":"2025-06-06T23:59:59+00:00","discovered_at":"2026-05-14T18:02:49.828256+00:00","generated_at":"2026-05-19T18:32:42.847733+00:00","sec_items":["5.07"],"event_type":"other","sentiment":"neutral","materiality_score":0.1,"calibrated_materiality_score":0.1,"confidence":"high","headline":"Relay Therapeutics stockholders elect directors and approve auditor at 2025 annual meeting","bullets":["Alexis Borisy elected class II director with 80.7M votes for, 43.0M withheld.","Mark Murcko elected class II director with 79.5M votes for, 44.2M withheld.","Non-binding advisory vote on executive compensation approved: 69.7M for, 53.9M against.","Ratification of Ernst & Young as auditor for FY2025 passed with 142.2M votes for."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-25-137162","json":"https://secwatch.observer/filing/0001193125-25-137162.json","markdown":"https://secwatch.observer/filing/0001193125-25-137162.md","text":"https://secwatch.observer/filing/0001193125-25-137162.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1812364/000119312525137162/0001193125-25-137162-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1812364/000119312525137162/d48764d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-19T18:32:42.847733+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}